P. Magerstedt

Radio-opaque liposomes for the improved visualisation of focal liver disease by computerized tomography.

A. Henze, J. Freise, P. Magerstedt, 1989, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.

Sterilization of contrast media (Isovist) containing liposomes by ethylene oxide.

A. Schaper, J. Freise, P. Magerstedt, 1989, Journal of microencapsulation.

Uptake of liposomes and sheep red blood cells by the liver and spleen of rats with normal or decreased function of the reticuloendothelial system

J. Freise, P. Magerstedt, W. Müller, 1981, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

Effect of liposome-entrapped methotrexate on ehrlich ascites tumor cells and uptake in primary liver cell tumor

F. Schmidt, J. Freise, P. Magerstedt, 1979, Journal of Cancer Research and Clinical Oncology.

Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients

M. Manns, F. Lehner, J. Klempnauer, 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Inhibition of phospholipase A2 by gabexate mesilate, camostate and aprotinine.

K. Schmid, J. Freise, P. Magerstedt, 1983, Enzyme.

Studies on the multiple forms of γ-glutamyltransferase

E. Schmidt, J. Freise, P. Magerstedt, 1976 .

Gabexate mesilate and camostate: new inhibitors of phospholipase A2 and their influence on the alpha-amylase activity in serum of patients with acute pancreatitis.

F. Schmidt, K. Schmid, J. Freise, 1985, Clinical biochemistry.

In vitro inhibition of phospholipase A2 by gabexate mesilate, camostate, and aprotinine

H. Wittenberg, J. Freise, P. Magerstedt, 1989, Klinische Wochenschrift.

Pharmacokinetics of liposome encapsulated cisplatin in rats.

H. Schmoll, J. Freise, P. Magerstedt, 1982, Archives internationales de pharmacodynamie et de therapie.